Virbac Animal Health has launched a twitter-based early warning system to alert vets and dog owners of cases of canine parvovirus (CPV) in their area. It is to go live on 1 November 2012.
@parvoalert is a twitter feed that updates followers on the geographic location of cases of the disease using the first half of the relevant postcode. The company is asking vets and owners learning of a case to tweet the first half of the postcode where it occurs to @parvoalert. Virbac will then retweet it to everyone else following @parvoalert. The company is also advising vets and owners to check the feed regularly for news of cases. The service is free.
Virbac says that when it hears of a case, it will also provide practices in 'at-risk' areas with a 'Parvo-alert' Pack, containing a range of tools and support materials to help them alert dog owners. These include waiting room posters, leaflets, stickers and template text for newsletters.
The Veterinary Director of Battersea Dogs & Cats Home, Shaun Opperman, said: "As recent viewers of ITV1's 'Paul O Grady: For the Love of Dogs' may have seen, parvovirus causes dreadful suffering to dogs. Unfortunately many people still aren't vaccinating their dogs, so we see cases on a regular basis and it's vital that owners vaccinate their dogs, are aware of the disease and remain vigilant for the early signs."
Simon Boulton MRCVS, Product Manager at Virbac, said: "One of the problems in tackling canine parvovirus is that little information is shared on the frequency and location of cases so, in some ways, it's a hidden problem. While it's not as common as some other infectious diseases, when outbreaks occur, as they did earlier this year in South Wales and Oxford, the disease proves fatal in around half of diagnosed dogs."
Once @parvoalert is established, Virbac says it aims to build it into a comprehensive web-based CPV resource, featuring background on the prevention and treatment of the disease; comment from veterinary experts and downloadable practice support materials.
Simon continued: "It's heart-breaking for owners to lose their pets in this way and to see them suffer from a disease that could easily have been prevented. We hope @parvoalert will help to raise awareness of the fact that CPV continues to represent a significant threat to unvaccinated dogs. It will benefit all practices in areas affected as they will receive a Parvo-alert Pack, which they can use to encourage their clients to get their dogs vaccinated and look out for signs of the disease."
The BVA has welcomed the decision to prohibit the advertising of antimicrobials directly to animal keepers from 2013 in a bid to reduce antimicrobial resistance.
The Veterinary Medicines Directorate (VMD) announced that the Veterinary Medicines Regulations will be revised next year. The change has come as a result of the European Commission's view that the UK did not correctly transpose the European Directive 2001/82/EC which prohibits the advertising of certain veterinary medicinal products to the 'general public'.
When the VMD consulted on proposals to restrict the advertising of antimicrobials to farmers in 2010 the BVA supported the measure as a sensible approach to the responsible use of antimicrobials.
In a letter to stakeholders the VMD explained that: "A number of interested parties from veterinary medicine hold the view that the advertising of antibiotics to keepers of animals leads to undue pressure to prescribe newer antibiotics, which can often be important in human medicine and are associated with the development of multiple resistances."
Peter Jones, President of the BVA, said: "The BVA has consistently argued for the restriction of advertising of antimicrobials to animal keepers and we believe this is the right decision.
"New antimicrobials are heavily advertised by pharmaceutical companies and there can be undue pressure put on veterinary surgeons by clients who want to try new products that promise good results, but which may not be appropriate from the point of view of responsible use.
"Antimicrobial resistance is a very serious issue for both animal and human health and we are pleased that the European Commission and the VMD have taken the view that the Regulations need to be revised.
"Ultimately, it is the veterinary surgeon who will make the decision on which veterinary products to use and vets will continue to work with their farm clients to ensure antimicrobials are used prudently and responsibly."
Two veterinary surgeons from the Animal Health Trust have won international awards for outstanding work in diagnostic imaging at 16th International Veterinary Radiology Association (IVRA) meeting held in Bursa Turkey.
Dr Sue Dyson, Head of Clinical Orthopaedics at the AHT, was awarded the IVRA J Kevin Kealy Award, which recognises members of the IVRA who have made substantial, scientific contributions to veterinary radiology.
The Award, established in 2003, is named in honour of Emeritus Professor J. Kevin Kealy, organiser of the first meeting of the IVRA, the first President, and an Honorary Member of the Association.
Sue has lectured internationally and published more than 200 refereed papers in scientific journals, as well as being a major author and editor of four books. On receiving the award, she said: "I was hugely surprised to receive this award and feel extremely honoured."
Past president of the IVRA, Peter Lord, said: "It is hard to imagine that equine diagnostic imaging today would be the same without the contributions of Sue Dyson and her colleagues. She is an outstanding recipient of the J Kevin Kealy Award."
Ruth Dennis, Head of Diagnostic Imaging (pictured above right), was awarded the European Association of Veterinary Diagnostic Imaging (EAVDI) Douglas and Williamson Award, established in 1983, to recognise outstanding achievement within the field of veterinary diagnostic imaging.
Ruth was President of the EAVDI between 2000 and 2002 and her long standing contributions to the association have been recognised with this award.
Ruth said: "I am very honoured to receive this award, especially since, as a vet student in Cambridge in the late 1970s, I was taught by Sidney Douglas and David Williamson, who were pioneers of veterinary radiology."
Nuria Corzo-Menendez, current EAVDI President, said: "Ruth's contributions to veterinary diagnostic imaging are vast and we will always be grateful for such great additions to our field."
Animalcare has released further information about Vitofyllin (propentofylline), its new CNS stimulant for dogs.
According to the company, Vitofyllin helps restore vitality and willingness to exercise, especially in the senior dog, by improving peripheral and cerebral vascular blood circulation. It is indicated to help improve dullness, lethargy and overall demeanour in dogs. In addition it has a bronchodilatory activity equivalent to amilophylline (a salt of theophylline)
Animalcare says that with dogs living longer, age-related problems are on the increase. The company highlights the example of Cognitive Dysfunction Syndrome (CDS), a neurodegenerative disease that affects older dogs. CDS is characterised by various pathological processes with signs that include disorientation, changing interaction with people or other pets, sleep-wake cycle alterations, soiling in the house and decreased activity levels.
The company says these subtle behavioural changes are unlikely to be picked up at a routine annual check. Indeed, in one study 75% of owners of dogs aged over 7 reported at least one behavioural sign consistent with CDS, however only 12% reported their concerns to a vet.2
Vitofyllin is available in 50mg and 100mg strengths in blister packs containing 56 tablets. Presented as 'easy to administer' four-way split cross-snap-tabs which can be divided into halves or quarters to enable more accurate dosing to be achieved whatever the weight of animal, even down to 2.5kg bodyweight.
Vitofyllin is POM-V licensed and has a 3 year shelf-life. Waiting room posters and client leaflets are available to support recognition of behavioural signs by clients and practice staff.
Further iinformation, and details about a special launch offer are available from local Animalcare representatives.
Reference
Royal Canin has announced it is to launch Catom, a piece of software developed to help educate cat owners during veterinary consultations, at this year's London Vet Show.
Initially, the software will be available for PC and Mac, with iPad and Android versions coming by the end of the year.
You can can find out more by visiting Royal Canin's stand at the London Vet Show, where the company says it will have a large touch-screen TV displaying the software, along with laptop demos running throughout the exhibition.
Dorwest Herbs has launched its annual 'Dorwest Say Relax' fireworks phobia campaign, which includes free promotional packs for practices.
The promotional packs, which contain a poster, leaflets, flashing badges and a 'Dorwest Say Relax' t-shirt, being given free to the first 100 practices that request a product box (containing licensed Scullcap & Valerian Tablets and Organic Valerian Compound at a discounted price) from the company.
In addition, Dorwest is running a seemingly popular consumer facebook competition to find the most relaxed dog in the nation, the winner of which will be sent on a pet-friendly luxury weekend break.
Finally, the company is writing a blog written from the perspective of Merlin, the dog used in its logo - http://merlintakescontrol.wordpress.com - though quite who is going to read it, or why, is slightly beyond me.
The Animal Health Trust has presented the results of a study which has identified a significant link between hind limb lameness and saddle slip, showing consistent saddle slip in some horses with hind limb lameness, even when the lameness is fairly subtle and difficult to detect.
According to the AHT, saddle slip in sports horses is a well-recognised problem that can occur for a variety of reasons, including asymmetry in the shape of the horse's back, riders sitting crookedly and ill-fitting saddles. Sue Dyson, Head of Clinical Orthopaedics at the Centre for Equine Studies at the Animal Health Trust, had also observed that saddle slip may occur because of hind limb lameness. The intention of the study, therefore, was to find out more about the interrelationships between the horse, saddle and rider and to document the frequency of occurrence of saddle slip in horses with hind limb lameness compared with other horses.
The research was undertaken by Sue Dyson and Intern Line Greve and was presented at the British Equine Veterinary Association (BEVA) Congress last month. It is thought to be the first study of its kind, and was supported by the Saddle Research Trust (SRT). The SRT is a charitable organisation, aiming to facilitate research and provide support as well as advice on the influence of the saddle on the welfare and performance of horses and riders.
The study assessed 128 horses of varying size, age and type. The degree of lameness of each horse was graded; back shape and symmetry were measured and saddles assessed for symmetry and fit. Each horse was ridden by at least two riders and rider straightness plus weight were recorded. The grade of saddle slip, whether it occurred with more than one rider, and whether saddle slip was influenced by the direction of movement or the diagonal on which the rider was sitting were also noted.
The saddle consistently slipped to one side in 54% of horses with hind limb lameness, compared with 4% of horses with fore limb lameness, 0% with back pain and/or sacroiliac joint region pain and 0% of non-lame horses. Diagnostic analgesia was subsequently used to abolish the hind limb lameness and this eliminated the saddle slip in 97% of cases.
Sue said: "Our findings emphasise the need to educate owners, veterinarians, physiotherapists, trainers, riders and saddle fitters that saddle slip is frequently an indicator of lameness, not necessarily a manifestation of an ill-fitting saddle or asymmetric shape of the horse's back. Detection of saddle slip provides an opportunity for the owner, riders and trainers to detect low-grade and subclinical lameness, with important welfare consequences."
Further scientific studies are planned, with the support of the Saddle Research Trust, in order to build on these findings. To this end the SRT is currently seeking an honorary fundraiser to help secure ongoing financial support. For further information contact Anne Bondi on 07775 912202 or email annebondi@me.com.
1An investigation of the relationship between hindlimb lameness and saddle slip, L. Greve and S.J. Dyson, Centre for Equine Studies, Animal Health Trust, Lanwades Park, Kentford, Newmarket, Suffolk, CB8 7UU, UK.
The Feline Advisory Bureau (FAB) has teamed up with Agria Pet Insurance to provide insurance cover for cats in the UK, with each policy generating a donation to the work of FAB and its International Fund for Cat Welfare.
Ross Tiffin, FAB's Strategy and Business Adviser said: 'In Agria, we have found a respected company that shares our ethos - it believes in sharing information to makes cats' lives better. One of the leading pet insurers in the world, Agria has been insuring pets since 1890 and has shared information on longevity and disease patterns with university researchers for many years.'
Claire Bessant, Chief Executive of FAB said: 'FAB has always been an enthusiastic supporter of health insurance for cats - we want cats to receive the best treatment without owners having to worry about the cost. Our support has now taken on a practical form in the shape of a general pet insurance guide and, through working closely with Agria, by providing cat owners with an excellent insurance option.'
To view A fabcats guide to cat insurance go to www.fabcats.org/catinsurance. The guide gives generic advice on choosing insurance.
For more information on Fabcats Cat Insurance from Agria go to www.fabcats.org/catinsurance or call Agria on 0800 369 9441.
Elanco Companion Animal Health has announced that its Duvaxyn IE and IE-T Plus vaccines have been licensed for active immunisation against OIE recommended clade 1 and clade 2 equine influenza strains, the first vaccines to be so licensed.
The company says the updated license is a result of a recent challenge study which demonstrated the ability of Duvaxyn IE-T Plus equine influenza vaccine to induce cross protection against clade 2 strain A/equi-2/Richmond/1/07 (H3N8) two weeks after two doses of the primary course1 were given. Cross-protection was further supported by another study2 measuring serum antibody response to the Richmond '07 strain 52 weeks after the three dose primary vaccination course.
The OIE (World Organisation for Animal Health) updated its equine influenza vaccine recommendations in 2010 to reflect the fact that all field strains characterised through 2008 and 2009 were of clade 1 or 2 of the Florida sub-lineage. The antigenic difference between viruses of these clades could potentially compromise the effectiveness of vaccines containing a representative of a single clade3.
Anna Jackson, national veterinary manager for Elanco Companion Animal Health UK, said: "Whilst no vaccine has been updated to match the current OIE recommendations, the results of our challenge study and subsequent licence update provide reassurance that horses vaccinated with Duvaxyn will be protected against clinical signs of disease caused by currently circulating strains of equine influenza, including those the OIE has identified as being of concern.
"Further reassurance is also given with the confirmation in our study that Duvaxyn IE-T Plus elicits a cell mediated immune response, recognised to play an important role to aid in viral clearance and further enhances protection against strains circulating in the field." 4
The live virus challenge study, conducted by the Animal Health Trust, involved two groups of EIV seronegative horses. The first group, consisting of seven vaccinates, were given two doses of Duvaxyn IE-T Plus, 28 days apart, and challenged with A/equi-2/Richmond/1/07 (H3N8) virus strain 14 days after the second vaccination. The second group of unvaccinated horses was challenged at the same time. Duvaxyn IE-T Plus caused a statistically significant reduction in both clinical signs of the disease and in viral shedding.
Duvaxyn IE-T Plus is the only inactivated whole virus carbomer adjuvanted equine influenza vaccine in the UK. According to Elanco, experts in the field of human vaccination have expressed the view that whole virus vaccines have the potential to induce a stronger and more broadly based response to circulating influenza strains than those contained in sub-unit vaccines because of the presence of the full set of virus proteins including the conserved nucleoprotein, which shows no antigenic drift, in the vaccine5.
References
The RCVS Charitable Trust has released the results of a survey that suggests a lack of available, high-quality research could be hampering the implementation of evidence-based medicine (EVM) in veterinary practice.
Of the 70 survey respondents, although 70% said they were familiar with the concepts of EVM, only 36% said that they always used EVM principles or that EVM principles were deeply embedded within their practices. When asked about the barriers to implementing EVM, many vets commented that there was a lack of high-quality research available to them.
Trust director, Cherry Bushell said: "This survey was relatively small as our intention is for it to help spark discussion at our forthcoming symposium 'The Sceptical Vet: Eminence or Evidence? Finding the best way forward for the veterinary profession'. We want to consider the possibility of developing a range of evidence-based resources for the veterinary profession, so it's interesting to hear vets commenting about the lack of an available, high-quality evidence base."
All those completing the Trust's survey were entered into a prize draw for a chance to have their travel expenses to the event reimbursed. Veterinary surgeon Ariel Brunn (top right) from Vets Now, Maidenhead, was the winner. She said: "I'm really looking forward to this Symposium and the discussion that will come with it - along with clinical governance, evidence-based practice provides a means to offer the best care for our veterinary patients. Having been a practising vet for less than 5 years, I'm excited to learn more about how EVM can be incorporated into veterinary practice and I'm certainly pleased to have won the prize draw to support my travel to this event."
This symposium will take place on Tuesday 30 October 2012, at Church House Conference Centre, London. A limited number of places are still available for practising veterinary surgeons and veterinary nurses only via the Trust (a.doorly@rcvstrust.org.uk or 0207 202 0741). For more information visit http://trust.rcvs.org.uk/grants-and-collaborations/the-sceptical-vet-eminence-or-evidence.
Pfizer Animal Health has launched Poulvac, the first modified live vaccine against E.coli in chickens.
The company claims that the vaccine, which can be used from one day of age, is set to bring major benefits in safeguarding the health of broilers, pullets for egg laying and breeding stock.
According to Pfizer, E.coli is one of the most significant bacterial pathogens found in chicks during the first week, leading to problems throughout the life of a flock including inferior performance, lack of uniformity and increased mortality. It is a costly, widespread problem for the UK poultry industry.
The vaccine was developed from research beginning in the 1990s at the Government's veterinary laboratories at Weybridge (now AHVLA) in the UK, employing genome technology to produce an avirulent strain of E.coli that induces protective immunity to the pathogenic strains of the bacteria.
The vaccine is completely non-pathogenic, and does not persist in the bird or the environment for any significant period of time. A gene deletion in its development restricts in vivo replication and leaves behind activated macrophages ready to respond to pathogenic E.coli strains.
Dr Stuart Andrews, poultry technical manager of Pfizer in the UK and Ireland said: "Poulvac E. coli provides broad cross protection against the key serotypes of E. coli infecting chickens. It is the only modified live, nonreactive vaccine proven to meet the European regulatory requirements for efficacy and safety.
"Trials have confirmed that Poulvac E.coli does not persist in the bird and proves to be self-limiting. The vaccine can survive in the environment for only a short time, and spread to in-contact birds is also limited."
The vaccine is administered as a coarse spray with onset of immunity 14 days afterwards and duration of immunity for up to 12 weeks. It can be used from day-old up to six weeks before the onset of lay, and has a nil day withdrawal period.
In the USA where Poulvac E coli has been available for six years field experience has shown the considerable benefits. In the Midwest where average layer mortality at 50 weeks of age was 2.31 per cent, this was reduced to 1.51 per cent with three doses of the vaccine*. In Eastern USA flock mortality compared with five previous flocks was reduced from over three per cent to one per cent.
A field trial in the USA with more than 300,000 broiler breeders vaccination before lay reduced mortality from 2.8 to 1.9 per cent - with only two out of 28 flocks needing antibiotic treatment compared with 13 of the 28 unvaccinated flocks.
On a broiler field trial in Georgia over four million birds were vaccinated with Poulvac E. coli at hatch. The vaccinated birds had a better feed conversion (1.79 against 1.84 for the controls) and with condemnations at the processing plant down from 1.22 to 0.73 per cent the result was a lower production cost of 0.51¢ per lb.
In another broiler trial covering more than two million birds in Arkansas livability was improved from 95.20 to 95.77 per cent and feed conversion improved from 1.95 to 1.90, gaining 0.45¢ per lb.
* Pfizer says it is important to note that in these studies carried out in the USA more than one dose of the vaccine was often administered. A single vaccination is licensed in the Summary of Product Characteristics however, where clinical disease requires and at the discretion of a veterinary surgeon, the vaccination schedule may be re-started as there is no contra-indication on the SPC.
Peter Harlech Jones has been elected President of the British Veterinary Association for 2012/2013. The ceremony took place during the Annual General Meeting of the BVA at the close of its Annual Congress, held in the Merseyside Maritime Museum in Liverpool.
Mr Jones, an international consultant on veterinary medicines, was born and raised in North Wales where he attended the Sir Huw Owen School in Caernarfon. He qualified from the University of Liverpool Veterinary School in 1971. After several years in practice in Wales and London - plus a spell in Ontario, Canada - Peter joined the pharmaceutical industry and spent 20 years in the animal health business both in the UK and overseas working in the fields of research and development and also regulatory affairs.
In 1995 he was appointed the first head of the Veterinary Division at the newly created European Medicines Evaluation Agency (EMEA) in London, playing a leading role in the creation of the new European regulatory system and working at the centre of European institutions. His last post before semi-retirement in 2008 was as head of the global animal health industry association, the International Federation of Animal Health (IFAH).
Within the BVA Peter has served on the Veterinary Policy Group and as chair of the Medicines Group and is a former secretary and chairman of the Association of Veterinarians in Industry (AVI). He participates in the work of the Federation of Veterinarians of Europe (FVE) and acts as a consultant to GALVmed whose aim is to make livestock vaccines, diagnostics and medicines accessible to those in developing countries for whom livestock is a lifeline.
Mr Jones said: "My background is in pharma research and international regulatory affairs and I am confident that my experience will be useful as we anticipate the new EU Animal Health Law and medicines legislation. But I am driven to do much more for the veterinary profession than just in those fields.
"The word 'value' really began to resonate for me when I started thinking of my theme for the year ahead as President of BVA.
"In whatever role we play vets are adding value in so many areas of our professional lives to society at large in a huge and significant contribution to the public good. I firmly believe that we, as an association and as a profession, must use every opportunity to reinforce the message about the value we give in all aspects of our work, and to believe in ourselves.
"I want to see a greater appreciation for what we do and what we contribute, and BVA will lead from the front.
"Looking ahead it will be a busy year for all of us. But I am confident that we have the teams in place - through our committees and council, our regional representatives, our divisions and beyond - to do our wonderful profession proud.
"I am certainly very proud to be standing here today and I am committed to working hard for all our members as their President."
The BVA Officer Team for 2012/13 is Peter Harlech Jones (President), Carl Padgett (Past President), and Robin Hargreaves (President Elect)
The BVA has announced that from 2013, its annual Congress will take place at the London Vet Show.
The association says that the move is being done to bring together political debate and clinical CPD on a large scale and to ensure that the BVA can reach an even wider audience with its representative and educational services.
The BVA and the Vet Show teamed up last year at London Vet Show 2011 to announce the launch of the BVA Careers Fair, which will be hosted at this year's London Vet Show on 15-16 November, and the start of a partnership that would ensure discounted Vet Show rates for BVA members.
2013 will also see two new clinical streams added to the London Vet Show programme creating a comprehensive CPD event for vets in small and mixed practice. Cattle and equine streams for mixed practitioners will be delivered by the BVA to run alongside the popular companion animal stream provided by the Royal Veterinary College.
The partnership will also see substantial discounts being offered to BVA members.
BVA President Carl Padgett said: "BVA's number one value is that our members are at the heart of everything we do. We know that members require good value, high quality and relevant CPD and we believe that our new partnership with the London Vet Show offers the best opportunity for us to provide members with exactly what they want.
"It's a significant move for BVA but one that makes complete sense. From 2013 we will be bringing together the contentious issue streams that are the bedrock of BVA Congress, with a high quality clinical CPD programme covering large and small animals, and one of the biggest and best veterinary exhibitions.
"We know we haven't attracted the delegate numbers we would like to have done in recent years and by partnering with the London Vet Show we have the opportunity to reach a much greater audience. It's a very exciting step forward for BVA."
Rob Chapman, Event Director for the London Vet Show, said: "We are all delighted to be developing our relationship with the BVA. To be able to host such an established and prestigious event as the BVA Congress at the London Vet Show is an honour for the Vet Show.
"Combining the long-standing history of the BVA with the rapidly developing reputation of the Vet Show gives us a great symbiotic relationship. The new clinical content that we will be working on together will help the event and that relationship even further offering great value for both Vet Show delegates and BVA members."
Invicta Animal Health has launched SynVet-50, a licensed synthetic Sodium Hyaluronate (HA), for intra-articular treatment of lameness caused by joint dysfunction associated with non-infectious synovitis in horses.
The product is Invicta's first licensed medicine.
According to the company, the functional mechanisms of HA are directly dependent on the molecular weight and concentration of HA. 1 Therefore, SynVet-50 has been formulated with a molecular weight of 1.5m Daltons which is the highest of any synthetic HA available in the UK.
Invicta says that at 20mg per ml, SynVet-50 is also the most concentrated HA available.
Storage is at ambient temperature.
SynVet-50 is a 2.5ml solution containing 50mg HA, conveniently presented in a 5ml glass syringe.
Rob Watkins, Managing Director of Invicta said: "We are excited to be launching our first licensed medicine in the UK. The management team of Invicta have over 10 years experience in this market which has allowed us to provide a product strongly focussed on the clinicians needs, not just in terms of technical ability, but also in convenience of presentation".
For further information see www.invictavet.com or phone 01403 791313
Norbrook Laboratories has launched Norfenicol Solution for Injection (florfenicol), a broad spectrum antibiotic licensed for the treatment of pneumonia in cattle and pigs.
Dr Barry McInerney, Norbrook's GB Veterinary Advisor said: "With many farmers preparing for winter housing, the launch of Norfenicol is timely as pneumonia represents the most common disease of housed cattle in the UK costing the agricultural industry an estimated £80m per year. Norfenicol is an easy to inject, cost effective treatment of pneumonia which kills bacteria quickly, and is available in a durable plastic bottle. Studies have shown florfenicol, the active ingredient in Norfenicol, to have a high bacteriological and clinical efficacy (100% and 96% respectively) against susceptible bacteria in the treatment of calf respiratory tract diseases."
Norfenicol is indicated for the treatment of bacterial respiratory disease in cattle associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somniand for the treatment of acute outbreaks of respiratory disease caused by strains of Actinobacillus pleuropneumoniae, and Pasteurella multocida in swine.
Dr McInerney added: "NSAIDs have also been shown to be a beneficial ancillary therapy in treating bacterial pneumonia, to alleviate pain as well as to reduce inflammation and pyrexia. Norbrook has a range of NSAID products which are available as an adjunctive treatment for pneumonia in cattle, including Loxicom 20 mg/ml solution for injection for cattle, pigs and horses."
For further product information, visit www.norbrook.com
The Kennel Club has announced that crossbreed dogs are to have their own event at Crufts for the first time next year.
For the first time in its twelve year history, the grand final of Scruffts, the crossbreed dog competition run by the Kennel Club, will culminate at Crufts at the NEC in Birmingham. The winners of the four Scruffts categories - Child's Best Friend, Golden Oldie, Prettiest Crossbreed Bitch and Most Handsome Crossbreed Dog - will battle it out for the ultimate title of Scruffts Family Crossbreed of the Year.
Scruffts, sponsored by James Wellbeloved, has held heats across the UK over the course of the year and the winners of each category in every heat have been invited to Discover Dogs in London to compete in the class finals on Saturday 10th November. Winners of the four classes at Discover Dogs will now go on to Crufts 2013, where they will compete for the overall Scruffts title.
Caroline Kisko, Secretary of the Kennel Club, said: "Scruffts is a fantastic competition and we're very much looking forward to seeing the four class winners come to Crufts for the final next year. We have had some fantastic Scruffts champions in the past and I am sure we can expect to see a really special dog take the title once again."
There is still time to qualify for the Scruffts class finals, with heats taking place at CSJ Canine Max 2012 in Cirencester Park on Saturday 13th October and the East of England Autumn Show in Peterborough on Sunday 14th October.
The inaugural Vet Charity Challenge, which took place on 15th September at the Royal Agricultural College in Cirencester, has raised at least £20,000 for charity.
Twenty-six teams of four people took part, spending seven hours walking, running, cycling, kayaking, orienteering, along with a few mental physical challenges along the way.
The Challenge started in the morning with a sprint to collect puzzles for teams to solve. This determined time slots when teams could attempt six mental and physical puzzles during the morning session. The teams then headed off on a walk or run around the surrounding countryside. The aim was to visit as many points on the map as possible. Each team could choose its own route. After lunch, the teams headed off again for the cycling stages, visiting places on the map in order to gain more points. Then finally it was onto the water for the kayaking stage.
The winning team was the Complete Animal from Hyde Park Veterinary Centre in London. Team captain Leah Morley said: "The event was great fun, really well organised, and all the teams seemed to have got right behind it. You really had to work as a team, playing to different peoples strengths both physically and mentally. Everyone had a fair chance of winning. We would really like to thank others in the practice and our clients who were massively generous in their support and sponsorship. Their response was quite inspirational and certainly had an impact in driving us to perform well. I think every practice should take part and we look forward to returning next year to defend our title."
All the teams enjoyed the day and met the challenges head on and were enthusiastic for the Vet Charity Challenge to continue next year. Head Nurse Angella McNellan from Glenbrae Veterinary Clinic in Bearsden, Glasgow said: "The Vet Charity Challenge has been brilliant fun, beautiful scenery, great challenges. It has really helped get fitter through training as a team after work during the summer. We cannot wait to do it all again next year."
Roger Dixon MRCVS from Ashbrook Equine Hospital in Cheshire said: "The Challenge has been great fun, we really enjoyed the teambuilding element. Also it was worth the pain to beat the farm team!"
Nicolette Hayward from team The Far Canals said: "The Vet Charity Challenge has been superb, enormous fun. We did absolutely no training and came in fourth, so we are very happy with that result."
Jason Rogers from BCF team Witness the Fitness said: "We really enjoyed the day, found it exhausting though, the kayaking was the toughest part, and we had quite a run back in the morning to get back in time."
To add to the level of exhaustion competitors were flung around the dance floor for a Ceilidh following a barbeque in the evening. The band consisted of organisers from the event including caller Brian Wright from Vets Now and competitors Nicolette Haywood and Jim Hughes.
For more information, see more photos and to register interest for the challenge in 2013 visit www.vetcharitychallenge.co.uk. Also follow Vet Charity Challenge and on Twitter @vetchallenge.
Petplan has announced that it has raised £1million for the Blue Cross in the past decade.
The funds have gone towards running a dozen rehoming centres for dogs, cats, horses and rabbits, as well as four major animal hospitals across the country.
Petplan offers four weeks free insurance to adopters of dogs, cats and rabbits from Blue Cross as well as many other animal charities across the UK. All animal charities who work with Petplan receive 10% of the premium for any full policies they generate. The company says that in 2011, it raised over £2million for animal charities this way.
Petplan says that in addition to creating additional funds for the charity, providing four weeks free pet insurance also gives charities peace of mind that if the pet should require veterinary treatment the adopter has the funds available to ensure the animal receives the care it needs. This also means that the animal is less likely to be returned to the charity because the adopter can't afford the veterinary fees or that the charity will be asked to help cover the cost of treatment.
Chief Executive of the Blue Cross, Kim Hamilton, said: "As a charity that does not receive any government or lottery funding, we rely solely on donations from the public and valuable funding from our corporate partners. Petplan understands that our primary focus is animal welfare and the income generated from working with them has enabled us to give even more pets a healthy life in a happy home."
Simon Masding, Petplan's Head of Sales and Partnerships said: "At Petplan we work with over 1,700 animal charities and therefore understand the financial struggles that charities face on a daily basis. Along with offering charities commission Petplan also run the Charity Cheque initiative. When a four weeks free pet insurance voucher is activated it automatically enters the charity into a monthly prize draw to win £500."
For more information on how your animal charity can work with Petplan please visit www.petplan.co.uk/charity or call Charityline on 0800 072 8877.
The BSAVA has announced Richard Dawkins as its headline speaker at BSAVA Congress 2013 next April.
Richard follows in the footsteps of Lord Robert Winston and Susan Greenfield as the special speaker for the BSAVA lecture.
The talk, sponsored by Anistel, takes place on the Thursday afternoon of in Hall 1 and is open to all Congress delegates.
Dawkins is a prolific writer who first came to prominence with his 1976 book The Selfish Gene, his strident manifesto for secularism. However it is The God Delusion that now finds him so frequently called upon for comment. Along with Stephen Hawkins, he is one of the few scientists that members of the public can easily identify, in part due to his willingness to engage in academic and media debates.
Dawkins was born in Nairobi in 1941 where his father worked for British colonial service. He returned to Britain after the war to grow up on the family's estate farm. He studied zoology at Balliol College, Oxford, where he was tutored by Nobel Prize-winning ethologist Nikolaas Tinbergen, graduating in 1962. He received his M.A. and D.Phil. degrees by 1966, and remained a research assistant for another year, when his research concerned models of animal decision-making.
He has since been an assistant professor of zoology at the University of California, Berkeley, and a lecturer and reader in zoology at University of Oxford. In 1995 he was appointed Simonyi Professor for the Public Understanding of Science, a position that had been endowed by Charles Simonyi with the express intention that the holder "be expected to make important contributions to the public understanding of some scientific field", and that its first holder should be Richard Dawkins.
Image courtesy Zoe Margolis
Petplan Equine has announced the finalists for the fifth annual Petplan Equine Vet of the Year Award.
The winner of the award award, which is sponsored by Petplan Equine in association with Horse & Rider magazine, will be announced at the annual Animal Health Trust Equestrian Awards, being held at London's Lancaster Hotel on Thursday 1st November, 2012.
The finalists are:
Jess Hill BVM&S MRCVS Woodlands Veterinary Clinic, Cheltenham, Glos, EnglandJess, who qualified in 2003 at the University of Edinburgh Royal (Dick) School for Veterinary Studies, is described as simply "brilliant" for her outstanding calm, capable and kind approach to her work and the way in which she makes herself readily available to her clients. One nomination typifies all those received in praise of Jess' work: "She is incredibly knowledgeable and dedicated and nothing is too much trouble. She is great with horses - always quiet, kind and gentle. She works quickly and confidently, doesn't suggest unnecessary expensive procedures and is always cheerful and a pleasure to be with."
Keith Chandler BVMS Cert EP MRCVS, Kessock Equine Vets, Inverness, ScotlandKeith Chandler, a senior partner at Kessock Equine Vets received several nominations which credited not only him personally for his dedication, knowledge, pragmatic and caring approach but also his practice for its outstanding customer service. Upon receiving news of his nomination, Keith was swift to praise his team and explained: "This nomination reflects the exceptional team I have around me - together we strive to offer continuity, consistency and a minimum level of care to all our clients irrespective of which vet is in attendance."
Lee Paul, BSC BVM&S Cert EP MRCVS, Bushy Equine, Gwaelod-y-Garth, WalesNominations for Lee Paul, a specialist in internal and stud medicine who qualified at Edinburgh University's Royal Dick Veterinary School in 2002, unanimously praised his willingness to 'never give up' and to go beyond the call of duty. He is said to be highly dedicated and is praised for his willingness to always be available such as on the occasion when a horse he had been treating for a swelling in her throat presented complications during a weekend when he was not on duty. Despite this Lee, who had been contacted by the duty vet for background information, attended the call himself within an hour complete with the stethoscope he'd collected from the surgery en route and with his family in his car!
This year's judges were David Stickles, Head of Fund Raising at the Animal Health Trust, Alison Bridge, Editor of Horse & Rider magazine, Ben Mayes, President of the British Equine Veterinary Association (BEVA) and Gil Riley, 2009 Petplan Equine Vet of the Year.
Petplan says that the record number of high calibre nominations made it hard for the judges to choose three finalists. Isabella Von Mesterhazy, Head of Marketing for Petplan Equine said: "Anyone motivated to nominate their vet for this award must hold them in extremely high regard so once again we were very impressed by both the quality and quantity of nominations we received. It is heartwarming and inspiring to read the submissions that describe the outstanding contributions made by all the nominees in keeping owners happy and horses healthy. It has not been easy to select just three to go through to the final."
The winner will be posted on www.petplanequine.co.uk on Friday 2 of November.
Vetark has launched Aqua-Sed, a fish anaesthetic which has obtained the first permit for use as a fish euthanasia product.
Vetark says the new product enables the humane euthanasia of seriously ill or severely injured fish, as well as being a sedative to facilitate fish handling.
The new product incorporates a dosing pump to ensure accurate dosing, a critical aspect of fish anaesthetics.
The 250ml bottle and pump will be on sale at £13.13+VAT and is available under the Small Animal Exemption Scheme from Vetark.
Further information on fish anaesthesia visit the Vetark website on www.vetark.co.uk
The Kennel Club has written to veterinary surgeries in the UK to remind them to report caesarians and operations carried out on Kennel Club registered dogs, to help monitor and improve pedigree health.
The letter reminds vets that any operations which alter the natural conformation of a Kennel Club registered dog should be reported, as owners will need to apply for permission to compete with that dog at Kennel Club licensed shows. Vets are also asked to report caesarians as the Kennel Club will not register a litter from a bitch that has had two subsequent caesarians.
The Kennel Club says that information submitted by vets will ultimately help to improve the health of pedigree dogs as it 'provides information regarding breeding lines which may pass on certain defects and helps to deter breeders from breeding from animals with hereditary problems.'
The letter informs vets that breeders sign a declaration when registering their litter with the Kennel Club, which means that the vet will never be breaching confidentiality when reporting such operations. The declaration says: "I/we confirm and agree that any veterinary surgery performing a caesarian section and/or operation on any of my/our dogs in such a way that the operation alters the natural conformation of the dog or any part thereof may submit a report to the Kennel Club."
The declaration, regarding the reporting of operations which change natural conformation, was made a condition of Kennel Club registration in 1990 and caesarians were added to the declaration in 2010.
Caroline Kisko, Kennel Club Secretary, said: "The veterinary profession and the Kennel Club both hold valuable information about pedigree dogs but by sharing this information we will get a much more accurate picture about dog health.
Although some vets report operations to the Kennel Club this is not a uniform practice, but we hope this reminder will help to ensure that we work more closely together in the future."
Vets have been sent a copy of the reporting form that they should use and the link to where the forms can be downloaded from the Kennel Club website www.thekennelclub.org.uk/item/3310. The BVA has also produced a list of frequently asked questions about veterinary reporting at www.bva.co.uk/publications_and_resources/Forms.aspx
The Royal College of Veterinary Surgeons Charitable Trust has awarded five new bursaries in its latest grants round.
Two student bursaries were for UK veterinary undergraduates to attend the British Science Festival in Aberdeen from 4-9 September 2012. The bursary winners were Liv Nathan (pictured on right), a third-year veterinary student at the Royal Dick School of Veterinary Studies, and Alahel Mahdmina, a second-year veterinary student at the Royal Veterinary College.
Liv said: "I am very enthusiastic about providing real-life context to science and giving people a space to consider issues arising around science."
The students were required to use their observations and experiences to help the Trust develop future outreach activities to inform and inspire public audiences about veterinary clinical practice and research. Their bursary packages covered all their attendance expenses over the four-day event. One of their achievements was to film an interview with Dr Maggie Aderin-Pockock MBE, a space scientist (pictured on left). Both students will be reporting back in full to the RCVS Charitable Trust with their ideas at the end of October.
Two further bursaries were given to attend a joint symposium on antimicrobial resistance (AMR): 'Antimicrobial Resistance in Human and Veterinary Medicine - One Health, One Problem' to be held at the Royal College of Physicians, London, on Tuesday 2 October 2012.
One winner was Cahir King, a practitioner from Downe Veterinary Clinic in County Down, Northern Ireland. He said: "It will be a privilege to attend a symposium at which so many experts in their field will be speaking. Any vet who has worked on farms will be more than familiar with bugs that are resistant to antibiotic treatment."
The other winner was James Swann, a Junior Clinical Training Scholar (Small Animal) at the Royal Veterinary College. James said: "I am particularly interested in the application of clinical audit in practice to assess problems like AMR, and design effective strategies to deal with them. I believe it should be possible to provide simple audit kits for practices to download and implement, removing much of the inertia that prevents such ideas from being initiated."
The bursary winners will be offered free delegate passes, including lunch, worth £90, and travel expenses.
The final bursary is to attend the Veterinary Biomedical and Pharma Sciences (VBMPS) Congress on 15-16 October, in Birmingham.
The winning entry was from Alexander Stoll, a final-year student at the Royal Veterinary College, who acted as the Royal Veterinary College and UK student ambassador to the European Commission for the 'One Health' message. The Trust was impressed with Alexander's enthusiasm and active engagement in subjects related to One Health. He is a member of the Royal Society for Public Health and a member of the Society of Biology.
Alexander said: "I hope to be inspired to enter a cross-disciplinary career path and also to communicate the potential of a One Health approach, inspired by this congress."
Alexander won a package that includes entry to the conference and admission to all scientific sessions, worth £175, as well as transport costs and overnight food and accommodation.
The RCVS Disciplinary Committee has accepted an application for restoration to the RCVS Register by Gordon Lonsdale, who had been struck off in March 2004 for illegally delegating acts of veterinary surgery to insufficiently qualified members of his practice staff.
At the initial Inquiry, Mr Lonsdale, who formerly worked as a sole practitioner in Shropshire, had admitted three separate charges of serious professional misconduct. These included allegations that he had instructed nurses and support staff to undertake dental extractions, dog and cat castrations, the removal of tumours or masses, the induction and maintenance of anaesthesia, lancing abscesses and suturing wounds.
At yesterday's hearing, the onus was on Mr Lonsdale to satisfy the Committee that he was fit to be restored to the Register, not least in view of his former health problems and the eight-year period for which he had been off the Register.
He provided the Committee with evidence of undertaking continuing professional development, including 130 hours of online courses and seven weeks of seeing practice, letters of endorsement from former clients and testimonials from friends and former colleagues.
The Committee accepted Mr Lonsdale's evidence that he had successfully addressed his alcoholism, which it recognised as being a contributory factor to his poor decision making in an isolated working environment. He assured the Committee of his intention that, should his application be successful, he intended to work only in a multi-handed, rather than single-handed, practice in future.
The Committee found him to be an honest and frank witness who had made a credible attempt to refresh his small animal practice knowledge; it was satisfied that he accepted the findings of the original hearing and that he had put the welfare of animals at risk, and it noted his expression of remorse.
In considering Mr Lonsdale's application, the Committee made a number of recommendations, including that he should register for the RCVS Professional Development Phase, undertake certain parts of the RCVS Certificate in Advanced Veterinary Practice, restrict himself to his recognised areas of competence, investigate communication courses run by the Veterinary Defence Society and continue with the mentoring programme provided by the Veterinary Surgeons Health Support Programme. Mr Lonsdale stated that he was willing to follow all of these recommendations.
Professor Peter Lees, who chaired and spoke on behalf of the Disciplinary Committee, concluded: "In these circumstances, we do not consider that any further period of erasure would be of benefit either to the public or the veterinary profession. Therefore, we direct the Registrar to restore Mr Lonsdale's name to the Register."
Animalcare has announced the UK and Ireland launch of Vitofyllin, a central nervous system stimulant for older dogs suffering from dullness, poor demeanour and unwillingness to exercise.
The launch of Vitofyllin is the result of a collaboration between Animalcare and three European partners.
The company says the project has enhanced its in-house expertise because the active ingredient for the product was unavailable in the market and had to be contract synthesised, a first for a new product development at Animalcare. The regulatory procedure was also the first time a bioequivalence bio-waiver had been successfully applied for and obtained in Europe. This made the development quicker, more cost effective, less risky and importantly avoided the need for animal testing.
Animalcare says that as in previous years, it has set itself a target of launching four new veterinary medicines during the year. This launch is the first of those planned for the new financial year.
Stephen Wildridge, CEO of Animalcare Group, said: "We are very pleased to be able to add our new generic medicine Vitofyllin to our range of licensed veterinary medicines. The launch represents the culmination of the biggest development project undertaken by Animalcare and is the product of successful collaboration with members of our European partnership network."